Valneva SE (VALN) Common Equity (2019 - 2026)

Valneva SE (VALN) posted quarterly Common Equity of $87.3 million for Q1 2026, down 56.24% year-on-year from $199.4 million in Q1 2025, and down 27.76% on a QoQ basis from $120.8 million in Q4 2025.

Valneva SE (VALN) Common Equity (2019 - 2026) Analysis & Trends

Valneva SE (VALN) has reported Common Equity for 8 consecutive years, with $87.3 million the latest figure, recorded in Q1 2026.

  • Quarterly Common Equity fell 56.24% year-over-year to $87.3 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $87.3 million (down 56.24% YoY) and the FY2025 annual result came in at $120.8 million, down 41.43% from the prior year.
  • Common Equity declined to $87.3 million in Q1 2026 per VALN's latest filing, from $120.8 million in the prior quarter.
  • Over the last five years, Common Equity for VALN reached as high as $250.1 million in Q4 2022 and fell as low as $18.4 million in Q1 2022.
  • A 5-year average of $160.8 million and a median of $189.2 million in 2024 frame the typical range for Common Equity.
  • The largest YoY upside for Common Equity was 1292.35% in 2022 against a maximum downside of 94.64% in 2022.
  • Year by year, Common Equity stood at $250.1 million in 2022, then tumbled by 41.65% to $145.9 million in 2023, then surged by 41.33% to $206.3 million in 2024, then plunged by 41.43% to $120.8 million in 2025, then dropped by 27.76% to $87.3 million in 2026.
  • According to Business Quant data, Common Equity over the past three periods registered $87.3 million, $120.8 million, and $171.2 million for Q1 2026, Q4 2025, and Q3 2025 respectively.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Common Equity (Qtr)
1 Oculis Holding AG 68,785.72 Bn 68,785.72 Bn - 251.12 Mn
2 Nanobiotix 1,895.57 Bn 1,895.51 Bn - -98.34 Mn
3 BeOne Medicines 471.35 Bn 466.56 Bn 1.35 Bn 4.76 Bn
4 NuCana 279.75 Bn 279.75 Bn - 32.36 Mn
5 Vertex Pharmaceuticals 120.24 Bn 113.00 Bn 2.59 Bn 19.36 Bn
6 Regeneron Pharmaceuticals 67.80 Bn 59.04 Bn 3.31 Bn 31.42 Bn
7 Belite Bio 62.51 Bn 62.51 Bn - 795.79 Mn
8 Argenx Se 57.38 Bn 57.38 Bn 1.41 Bn -
9 Revolution Medicines 37.78 Bn 37.78 Bn - 1.50 Bn
10 Valneva SE 803.90 Mn 680.66 Mn 5.38 Mn 87.28 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 87.28 Mn
Dec 31, 2025 120.81 Mn
Sep 30, 2025 171.24 Mn
Jun 30, 2025 212.15 Mn
Mar 31, 2025 199.43 Mn
Dec 31, 2024 206.26 Mn
Sep 30, 2024 247.47 Mn
Jun 30, 2024 189.22 Mn
Mar 31, 2024 215.34 Mn
Dec 31, 2023 145.94 Mn
Sep 30, 2023 179.25 Mn
Jun 30, 2023 217.02 Mn
Mar 31, 2023 233.03 Mn
Dec 31, 2022 250.12 Mn
Sep 30, 2022 20.03 Mn
Jun 30, 2022 20.03 Mn
Mar 31, 2022 18.40 Mn
Dec 31, 2021 17.96 Mn
Sep 30, 2021 374.05 Mn
Jun 30, 2021 87.70 Mn